Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Actually ken, PCR can be used on saliva too, ncyt have a test currently on the market from July compatible with existing machines and require little change to work flow. Not deramping, just correcting an inaccuracy.
Then the results will need to be recorded and stored on a database securely.
Why?
You are infected. Go home, stay home till next test says ok
Or
Or ooo you are very poorly and need covid treatment and isolation in special unit
Not sure where the database is needed?
That would be a Carclo Investor. Not me.
I cannot offer any comment on Carclo due to an NDA or will I as that would be inside information!
The hold-up could also be the administration of selection of patients and physical distribution. Who will take these decisions and on what basis? There will presumably be many people who will only want a supply of LTFs to sell elsewhere.
Then the results will need to be recorded and stored on a database securely. The AppDX may be the solution for this - hence the government subsidy for development - and the app will require authorisation by Apple and others before distribution.
These issues will be made complicated by the lack of an ID database and a secure allocation of on ID number to one person in the UK.
No, unfortunately I can't. I just know that there are orders for that amount of containers for spittle which will be used for accurate Covid19 testing. If the NHS are expecting to collect that amount of containers then there must be a test which they will be supplying this into. That is not for PCR is it? They use swabs.
HI Rich, can you elaborate on the orders of 100m+ for the spittle vessels please?
You can be sure when the numbers are in place, the order books will be full. I am totally confident that Avacta will provide the best S&S in the diagnostics world and it will be a world beater.
I expect we will learn much more next Monday and have an update on the timing on the POC LFA test.
In the meantime we are still expecting BAMS and that can and should still give an huge boost to testing capacity with the right machines and lab capacity being made available. Don't forget saliva is the key carrier for the Covid19 virus and from samples of saliva spittle the S&S is much easier to get 100% right. This brings me to another part required which is a vessel to store spittle. There are companies in production of these already with orders over 100 million units! A fact.
So I think we are close to much more news and remain totally happy with my investment here!
Cheers, Rich
There is a lot of people talking about the tests and validation here. We are can see one massive market. I work in manufacturing sector and have multiple access in to medical device manufacturing businesses. For Avacta the test is made up of three key components.
1. The Affimer combination made and produced by Avacta and this is the critical bit! It determines the sensitivity and specivity of the test.
2. The membrane technology which comes from Cytiva which is very specialised hence there key involvement
3. The casing - this is an injection moulded component made of polymer, usually chosen to match the test use.
The first two are specialist technologies which are already covered. The third sounds easy. But this is a critical part and needs specialist tooling. The moulded part will come from a multi cavity tool with usually 8, 16, 32 or 48 cavities. The tool would be split into a male and female part (front and back if you like). The tooling for such projects is typically in the cost range of £400K to £600K per tool. One tool could potentially run at 360 cycles per hour. If we take a 16 + 16 tool (32 cavities) then you would produce 5760 pairs per hour or 138,240 per day. A moulding machine to run that tool, costs with equipment around it around £350K per machine. There are already multiple manufacturers who will be making these parts for existing lateral flow diagnostic testing. But, the challenge is increasing the number of machines and tooling. This is a key area and the sub-suppliers will be to companies like BBI and Abingdon Health. The question for these manufacturers is after the investment how long will this product be required and who is funding these projects. To make 10 million tests per week, you would need 72 sets of machines and tools in multiple suppliers.
You can be sure there will be multiple companies building capacity to do just this. Part of the time frame here is the lead-times of specific tooling which can be up to 16 weeks. Only Avacta, BBI and Abingdon know how big there current supply chain is to fulfil the huge demand required for all the current projects. These details are very important to understand in the current situation. The tools can be made from a number of high quality tool makers around the world, so you can be sure that everything is being done to ensure they have capacity to expand. I think any delays being seen are most likely due to this capacity requirement. Avacta will need based on the target S&S requirements millions of test per day to meet demand and once the product is not only out there but showing it can be relied on in the field a huge ramp up.
The UK market alone is currently off the scale, let alone the needs across the whole planet.
This hopefully helps people understand better the full picture of just the cases for LFT.
Cheers, Rich